Aptevo Therapeutics Inc. (APVO) News
Filter APVO News Items
APVO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest APVO News From Around the Web
Below are the latest news stories about APTEVO THERAPEUTICS INC that investors may wish to consider to help them evaluate APVO as an investment opportunity.
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business UpdateThe Company's ALG.APV-527 Phase 1 Trial for the Treatment of Multiple Solid Tumors Continues to ProgressPlanning for APVO436 Phase 2 Trial Initiation in Both Relapsed/Refractory and Frontline AML OngoingExtended Cash Runway with $7 Million in Funding ... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching for Friday morning! |
Aptevo to Present at Bio-Europe ConferenceSEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, ... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayPre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday! |
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business UpdateAptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended June 30, 2023 and provided a business update, including duration of remission (DOR) data for its lead clinical candidate, APVO436. |
10 Oversold Value Stocks To BuyIn this piece, we will take a look at ten oversold value stocks to buy. If you want to skip an introduction to value investing and oversold stocks, then take a look at 5 Oversold Value Stocks To Buy. Value investing has multiple benefits, particularly for patient investors. Understanding the complexities of a firm’s business […] |
Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering/ Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical stage biotechnology company focused on developing novel immuno-oncology therapeutics, today announced the closing of its previously announced public offering of 2,221,550 shares of common stock at a purchase price of $0.62 per share, Pre-Funded Warrants to purchase up to an aggregate of 5,842,967 shares of common stock at a purchase price of $0.619 per Pre-Funded Warrant, |
Why Is Aptevo Therapeutics (APVO) Stock Down 33% Today?Aptevo Therapeutics (APVO) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering. |
Is AMD Stock the Next Big AI Play?Advanced Micro Devices (AMD) stock is in the news Wednesday as investors wonder if the tech company can succeed in the AI market! |
MTCH Stock Price Prediction: Can Match Group Rally 30% From Here?Match Group (MTCH) stock is on the move Wednesday after getting a new price prediction and rating from BTIG analyst Jake Fuller. |